SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRtw Biotech Regulatory News (RTW)

Share Price Information for Rtw Biotech (RTW)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.19
Ask:
2.21
Spread: 0.02 (0.913%)
Market Cap: $714.60m
RTW Live PriceLast checked at - London Stock Exchange

Intraday Rtw Biotech Share Chart

Net Asset Value(s)

15 Jan 2020 07:00

RNS Number : 8057Z
RTW Venture Fund Limited
15 January 2020
 

LEI: 549300Q7EXQQH6KF7Z84

15 January 2020

RTW Venture Fund Limited

Net Asset Value

RTW Venture Fund Limited (the "Company") announces that the unaudited net asset value of the Company at the close of business on 31 December 2019 (the "NAV") was US$205.70 million, or US$1.27 per ordinary share.

As at 31 December 2019, 14.6 per cent. of the NAV was invested in privately-held companies.

For Further Information

RTW Investments, LP +1 (646) 343 9280Stephanie Sirota, Chief Business OfficerAlexandra Taracanova, PhD, Director of Investor Relations

Julia Enright, Business Development Associate

 

Estera (Company Secretary) +44 (0)1481 742 642Kevin Smith

 

Note:

1.

The NAV is determined by the Company's investment manager, RTW Investments, LP, in accordance with the Company's accounting policies. Investments by the Company in privately-held companies ("Private Portfolio Companies") have been valued at fair market value, taking into account the valuation prepared by Alvarez & Marsal Valuation Services LLC as at 31 December 2019 and the nature, facts and circumstances of the Private Portfolio Companies since that date. Investments by the Company in companies listed on a public stock exchange (the "Public Portfolio Companies") have each been valued by reference to their market capitalisation as at close of business on 31 December 2019. The Company applies a valuation discount to its investments in Public Portfolio Companies that are subject to post-IPO lock-up provisions.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVGPUGGGUPUGBC
Date   Source Headline
27th Sep 20247:00 amRNSBioAge Labs completes $198 million IPO
26th Sep 20247:00 amRNSGBP quote for the share class to cease
16th Sep 20247:00 amRNSMonthly Valuation Update and Factsheet
13th Sep 20247:00 amRNSHalf-year Report
14th Aug 20247:01 amRNSClosed Period Notification
14th Aug 20247:00 amRNSMonthly Valuation Update and Factsheet
6th Aug 20247:00 amRNSNew Investment in Jade Biosciences, Inc
22nd Jul 202412:00 pmRNSArtiva Biotherapeutics prices IPO at $167 million
15th Jul 20247:00 amRNSMonthly Valuation Update and Factsheet
11th Jul 20247:00 amRNSBaroness Blackwood Appointed as Independent NED
2nd Jul 20247:00 amRNSInvestment in Mirador Therapeutics & Santa Ana Bio
1st Jul 20247:00 amRNSTotal Voting Rights
14th Jun 20247:00 amRNSMonthly Valuation Update and Factsheet
13th Jun 20247:00 amRNSPositive Data Announcement - Avidity Biosciences
11th Jun 20247:00 amRNSPortfolio Company Numab Therapeutics Update
5th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20247:00 amRNSTotal Voting Rights
31st May 202412:00 pmRNSDirector Declaration
31st May 20247:00 amRNSTransaction in Own Shares
29th May 20247:00 amRNSHolding(s) in Company
28th May 20247:00 amRNSHolding(s) in Company
24th May 202412:00 pmRNSCancellation of Own Shares
16th May 20244:47 pmRNSResult of AGM
15th May 20247:01 amRNSTransaction in Own Shares
15th May 20247:00 amRNSAdditional Investment in Lycia Therapeutics
14th May 20247:00 amRNSMonthly Valuation Update and Factsheet
1st May 20247:01 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20244:46 pmRNSAnnual Financial Report
24th Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20249:30 amRNSNotice of AGM
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSMonthly Valuation Update and First Quarter Letter
12th Apr 20245:42 pmRNSPortfolio Company Update: Artios Pharma
12th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 202410:00 amRNSNew Investment: Obsidian Therapeutics
5th Apr 20247:01 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:01 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSAnnual Financial Report
27th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.